4 results
Search Results
Now showing 1 - 4 of 4
Publication Open Access Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border(2012-07-29) Amnat Khamsiriwatchara; Prayuth Sudathip; Surasak Sawang; Saowanit Vijakadge; Thanapon Potithavoranan; Aumnuyphan Sangvichean; Wichai Satimai; Delacollette, Charles; Pratap Singhasivanon; ประตาป สิงหศิวานนท์; Saranath Lawpoolsri; สารนาถ ล้อพูลศรี; Jaranit Kaewkungwal; จรณิต แก้วกังวาล; Jaranit Kaewkungwal; Mahidol University. Faculty of Tropical Medicine. Department of Tropical Hygiene; Mahidol University. Faculty of Tropical Medicine. Center of Excellence for Biomedical and Public Health Informatics.artemisinin-resistance containment project. METHODS: The eMIS had been functioning since 2009 in seven Thai-Cambodian border provinces. The eMIS has covered 61 malaria posts/clinics, 27 Vector-borne Disease Units covering 12,508 hamlets at risk of malaria... indicating potential drug resistance among patients. Data captured by the eMIS in 2008-2011 were extracted and presented. RESULTS: The core functionalities of the eMIS have been utilized by malaria staff at all levels, from local operational unitsPublication Open Access Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia(2012-08-28) Wichai Satimai; Prayuth Sudathip; Saowanit Vijaykadga; Amnat Khamsiriwatchara; อำนาจ คำศิริวัชรา; Surasak Sawang; Thanapon Potithavoranan; Aumnuyphan Sangvichean; Delacollette, Charles; Pratap Singhasivanon; ประตาป สิงหศิวานนท์; Jaranit Kaewkungwal; จรณิต แก้วกังวาล; Saranath Lawpoolsri; สารนาถ ล้อพูลศรี; Saranath Lawpoolsri; Mahidol University. Faculty of Tropical Medicine. Department of Tropical Hygiene; Mahidol University. Faculty of Tropical Medicine. Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS)was calculated. In addition, factors related to the delayed parasite clearance on day-3 post-treatment, were explored. RESULTS: A total of 1,709 P. falciparum-positive cases were reported during the study period. Almost 70% of falciparum cases received MAS... therapy (n = 1,174). The majority of cases were males, aged between 31 and 50 years. The overall MAS cure rate was > 90% over the three-year period. Almost all patients were able to clear the parasite within 7 to 14 days post-treatment. ApproximatelyPublication Open Access Are there any changes in burden and management of communicable diseases in areas affected by Cyclone Nargis?(2011-06-28) Myint, Nyan Win; Jaranit Kaewkungwal; จรณิต แก้วกังวาล; Pratap Singhasivanon; ประตาป สิงหศิวานนท์; Kamron Chaisiri; Pornpet Panjapiyakul; Pichit Siriwan; Mallik, Arun K.; Nyein, Soe Lwin; Mu, Thet Thet; Jaranit Kaewkungwal; Mahidol University. Faculty of Tropical Medicineoccurred in 2008 following Cyclone Nargis. A seasonal increase in ARI reached levels higher than usual in the months of 2008 post-Nargis. The number of malaria cases post-Nargis also increased, but it was less clear if this reflected normal seasonal... dropped sharply to 50% in the months of 2008 following the incident but then rose to 72% in 2009. CONCLUSION: While the incidence of diarrhea, dysentery and ARI increased post-Nargis in areas affected by the incident, the incidence rate for otherPublication Open Access Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized,non-inferiority, trial(2010-04) Awab, Ghulam Rahim; Sasithon Pukrittayakamee; ศศิธร ผู้กฤตยาคามี; Mallika Imwong; มัลลิกา อิ่มวงศ์; Dondorp, Arjen M.; Woodrow, Charles J.; Lee, Sue Jean; Day, Nicholas P.J.; Pratap Singhasivanon; ประตาป สิงหศิวานนท์; White, Nicholas J.; Kaker, Faizullah; White, Nicholas J.; Mahidol University. Faculty of Tropical Mediicnebe administered, dihydroartemisinin-piperaquine provides additional benefit in terms of post-treatment prophylaxis, reducing the incidence of recurrence from 4-8 weeks after treatment.